ID
37646
Beschreibung
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Stichworte
Versionen (1)
- 13.08.19 13.08.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
13. August 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Prior to Second Cycle
- StudyEvent: ODM
Beschreibung
Computed tomography
Alias
- UMLS CUI-1
- C0040405
Beschreibung
X-Ray Computed Tomography, Performed
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Beschreibung
X-Ray Computed Tomography, Changed status
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0443172
Beschreibung
X-Ray Computed Tomography, Finding
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0243095
Beschreibung
X-Ray Computed Tomography, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0011008
Beschreibung
Assessment of response
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
Beschreibung
Response to treatment, Evaluation, Performed
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beschreibung
Response to treatment, Evaluation
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beschreibung
Response to treatment, Evaluation Method
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C2911685
Beschreibung
Response to treatment, Evaluation, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0011008
Beschreibung
Response to treatment, Evaluation, Malignant Neoplasms
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0006826
Beschreibung
Serious adverse events
Alias
- UMLS CUI-1
- C1519255
Beschreibung
Status of the study
Alias
- UMLS CUI-1
- C0008976
- UMLS CUI-2
- C0449438
Ähnliche Modelle
Prior to Second Cycle
- StudyEvent: ODM
C0884358 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C2911685 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])